These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32337130)

  • 1. Anti-tuberculous Effects of Statin Therapy: A Review of Literature.
    Tahir F; Bin Arif T; Ahmed J; Shah SR; Khalid M
    Cureus; 2020 Mar; 12(3):e7404. PubMed ID: 32337130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin use and impact on tuberculosis risk.
    Su VY; Pan SW; Yen YF; Feng JY; Su WJ; Chen YM
    Expert Rev Anti Infect Ther; 2021 Sep; 19(9):1093-1098. PubMed ID: 33641582
    [No Abstract]   [Full Text] [Related]  

  • 3. Statin therapy reduces the mycobacterium tuberculosis burden in human macrophages and in mice by enhancing autophagy and phagosome maturation.
    Parihar SP; Guler R; Khutlang R; Lang DM; Hurdayal R; Mhlanga MM; Suzuki H; Marais AD; Brombacher F
    J Infect Dis; 2014 Mar; 209(5):754-63. PubMed ID: 24133190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small Molecule Mediated Restoration of Mitochondrial Function Augments Anti-Mycobacterial Activity of Human Macrophages Subjected to Cholesterol Induced Asymptomatic Dyslipidemia.
    Asalla S; Mohareer K; Banerjee S
    Front Cell Infect Microbiol; 2017; 7():439. PubMed ID: 29067283
    [No Abstract]   [Full Text] [Related]  

  • 5. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin therapy may prevent development of tuberculosis in diabetic state.
    Banerjee D; Bhattacharyya R
    Med Hypotheses; 2014 Jul; 83(1):88-91. PubMed ID: 24767940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin adjunctive therapy shortens the duration of TB treatment in mice.
    Dutta NK; Bruiners N; Pinn ML; Zimmerman MD; Prideaux B; Dartois V; Gennaro ML; Karakousis PC
    J Antimicrob Chemother; 2016 Jun; 71(6):1570-7. PubMed ID: 26903278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?
    Evans M; Rees A
    Drug Saf; 2002; 25(9):649-63. PubMed ID: 12137559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin Potentially Reduces Mycobacterial Severity through Its Action on Lipoarabinomannan and Drug Permeability in Granulomas.
    Davuluri KS; Singh AK; Singh AV; Chaudhary P; Raman SK; Kushwaha S; Singh SV; Chauhan DS
    Microbiol Spectr; 2023 Jan; 11(2):e0319722. PubMed ID: 36719189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin Use Is Associated With a Lower Risk of TB.
    Su VY; Su WJ; Yen YF; Pan SW; Chuang PH; Feng JY; Chou KT; Yang KY; Lee YC; Chen TJ
    Chest; 2017 Sep; 152(3):598-606. PubMed ID: 28479115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C-Type Lectin Receptor DC-SIGN Has an Anti-Inflammatory Role in Human M(IL-4) Macrophages in Response to
    Lugo-Villarino G; Troegeler A; Balboa L; Lastrucci C; Duval C; Mercier I; Bénard A; Capilla F; Al Saati T; Poincloux R; Kondova I; Verreck FAW; Cougoule C; Maridonneau-Parini I; Sasiain MDC; Neyrolles O
    Front Immunol; 2018; 9():1123. PubMed ID: 29946317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleiotropic effects of statins in atherosclerosis and diabetes.
    Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
    Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection and identification of specific glycoproteins and glycan biomarkers of macrophages involved in Mycobacterium tuberculosis infection.
    Tang XL; Yuan CH; Ding Q; Zhou Y; Pan Q; Zhang XL
    Tuberculosis (Edinb); 2017 May; 104():95-106. PubMed ID: 28454656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.